Revised Guideline on Clinical Investigation of Medicinal Products for Acute Coronary Syndromes

Summary

The EMA has published revised guidance on ACS clinical trials, updating endpoint definitions, minimum follow-up durations, and statistical considerations. The guideline introduces a composite primary endpoint hierarchy and provides updated recommendations for enrichment strategies and adaptive designs in ACS populations.